Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement (Chinese edition)

Journal of Chinese Integrative Medicine

Volumn 7, Issue 9, 2009, Pages 889-896

  Moher, David ^a,b   Liberati, Alessandro ^c,d   Tetzlaff, Jennifer ^a   Altman, Douglas G ^e   Altman, Doug ^e   Antes, Gerd ^f   Atkins, David ^g   Barbour, Virginia ^h   Barrowman, Nick ⁱ   Berlin, Jesse A ^j   Clark, Jocalyn ^h   Clarke, Mike ^k,l   Cook, Deborah ^m   D'Amico, Roberto ^c,d   Deeks, Jonathan J ⁿ   Devereaux, P J ^m   Dickersin, Kay ^o   Egger, Matthias ^p   Ernst, Edzard ^a   Gøtzsche, Peter C ^q   Grimshaw, Jeremy ^a   Guyatt, Gordon ^m   Higgins, Julian ^r   Ioannidis, John P A ^s   Kleijnen, Jos ^t,u   Lang, Tom ^v   Magrini, Nicola ^w   McNamee, David ^h   Moja, Lorenzo ^d   Mulrow, Cynthia ^h   Napoli, Maryann ^x   Oxman, Andy ^y   Pham, Ba' ^z,aa   Rennie, Drummond ^ab   Sampson, Margaret ⁱ   Schulz, Kenneth F ^b   Shekelle, Paul G ^a   Tovey, David ^h,ac   Tugwell, Peter ^b   more..

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY OF FREIBURG   (Germany)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h Veterans Health Administration ^*

ⁱ JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^j UK COCHRANE CENTRE   (United Kingdom)

^k MCMASTER UNIVERSITY   (Canada)

^l UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^m JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

ⁿ UNIVERSITY OF BERN   (Switzerland)

^o PENINSULA MEDICAL SCHOOL   (United Kingdom)

^p Nordic Cochrane Centre   (Denmark)

^q MRC BIOSTATISTICS UNIT   (United Kingdom)

^r KLEIJNEN SYSTEMATIC REVIEWS LTD   (United Kingdom)

^s UNIVERSITY OF IOANNINA   (Greece)

^t Tom Lang Communications and Training   (United States)

^u MAASTRICHT UNIVERSITY   (Netherlands)

^v Center for Medical Consumers   (United States)

^w Norwegian Health Services Research Centre   (Norway)

^x GLAXOSMITHKLINE   (Canada)

^y UNIVERSITY OF CALIFORNIA   (United States)

^z FAMILY HEALTH INTERNATIONAL   (United States)

^aa Southern California Evidence Based Practice Center   (Canada)

^ab Palliative and Supportive Care Review Group   (United States)

^ac Central Operations Unit   (United Kingdom)

more..

Author keywords

Meta analysis; PRISMA; Systematic review

Indexed keywords

CLINICAL RESEARCH; PREFERRED REPORTING ITEMS FOR SYSTEMATIC REVIEW AND META ANALYSIS; PUBLICATION; QUALITY CONTROL; REVIEW;

EID: 73849092832     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20090918     Document Type: Review

References (42)

1. Oxman AD, Cook DJ, Guyatt GH. Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group. JAMA. 1994; 272(17): 1367-1371.
2. Swingler GH, Volmink J, Ioannidis JP. Number of published systematic reviews and global burden of disease: Database analysis. BMJ. 2003. 327(7423): 1083-1084.
3. Canadian Institutes of Health Research. Randomized controlled trials registration/application checklist (12/2006) [2009-05-19]. http://www.cihr-irsc. gc.ca/e/documents/rct-reg-e.pdf.
4. Young C, Horton R. Putting clinical trials into context. Lancet. 2005; 366(9480): 107-108.
5. Mulrow CD. The medical review article: state of the science. Ann Intern Med. 1987; 106(3): 485-488.
6. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC. Meta-analysis of randomized controlled trials. New Engl J Med. 1987; 316(8): 450-455.
7. Sacks HS, Reitman D, Pagano D, Kupelnick B. Meta-analysis: an update. Mt Sinai J Med. 1996; 63(3-4): 216-224.
8. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reporting of meta-analysis of randomized controlled trials : The QUOROM statement. Lancet. 1994; 354(9193): 1896-1900.
9. Green S, Higgins J. Glossary. Cochrane handbook for systematic reviews of interventions 4.2.5. The Cochrane Collaboration [2009-05-19]. http://www.cochrane.org/resources/glossary.htm.
10. Strech D, Tilburt J. Value judgments in the analysis and synthesis of evidence. J Clin Epidemiol. 2008; 61(6): 521-524.
11. Moher D, Tsertsvadze A. Systematic reviews: when is an update an update? Lancet. 2006; 367(9514): 881-883.
12. University of York. Centre for Reviews and Dissemination [2009-05-19]. http://www.york.ac.uk/inst/crd/.
13. The Joanna Briggs Institute. Protocols & work in progress [2009-05-19]. http://www.joannabriggs.edu.au/pubs/systematic-reviews-prot.php.
14. De Angelis C, Drazan JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJ, Schroeder TV, Sox HC, Van Der Weyden MB; International Committee of Medical Journal Editors. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. CMAJ. 2004; 171(6): 606-607.
15. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet. 2004; 363(9418): 1341-1345.
16. Bagshaw SM, McAllster FA, Manns BJ, Ghali WA. Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence. Arch Intern Med. 2006; 166(2): 161-166.
17. Biondi-Zoccai GG, Lotrionte M, Abbate A, Testa L, Remigi E, Burzotta F, Valgimigli M, Romagnoli E, Crea F, Agostoni P. Compliance with QUOROM and quality of reporting of overlapping meta analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: Case study. BMJ. 2006; 332(7535): 202-209.
18. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ , Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions : explanation and elaboration. PLoS Med. 2009; 6(7): e1000100.
19. Altman DG, Schulz KR, Moher D, Egger M, Davidoff F, Elbourne D, Gotzsche PC, Lang T; CONSORT GROUP (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001; 134(8): 663-694.
20. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Moher D, Rennie D, de Vet HC, Lijmer JG; Standards for Reporting of Diagnostic Accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD explanation and elaboration. Ann Intern Med. 2003; 138(1): W1-W12.
21. Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M; STROBE initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) : explanation and elaboration. Ann Intern Med. 2007; 147(8): W163-W194.
22. Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG. Epidemiology and reporting characteristics of systematic reviews. PLoS Med. 2007; 4(3): e78.
23. Bhandari M, Morrow F, Kulkarni AV, Tornetta P 3rd. Meta-analyses in orthopaedic surgery: a systematic review of their methodologies. J Bone Joint Surg Am. 2001; 83-A(1): 15-24.
24. Kelly KD, Travers A, Dorgan M, Slater L, Rowe BH. Evaluating the quality of systematic reviews in the emergency medicine literature. Ann Emerg Med. 2001; 38(5): 518-526.
25. Richards D. The quality of systematic reviews in dentistry. Evid Based Dent. 2004; 5(1): 17.
26. Choi PT, Halpern SH, Malik N, Jadad AR, Tramér MR, Walder B. Examining the evidence in anesthesia literature: a critical appraisal of systematic reviews. Anesth Analg. 2001; 92(3): 700-709.
27. Delaney A, Bagshaw SM, Ferland A, Manns B, Laupland KB, Doig CJ. A systematic evaluation of the quality of meta-analyses in the critical care literature. Crit Care. 2005; 9(5): R575-R582.
28. Dickersin K. Publication bias: recognizing the problem, understanding its origins and scope, and preventing harm. In: Rothstein HR, Sutton AJ, Borenstein M. Publication bias in meta-analysis-prevention, assessment and adjustments. Chichester (UK): John Wiley &. Sons. 2005: 11-33.
29. Sutton AJ. Evidence concerning the consequences of publication and related biases. In: Rothstein HR, Sutton AJ, Borenstein M. Publication bias in meta-analysis - prevention, assessment and adjustments. Chichester (UK): John Wiley &. Sons. 2005: 175-192.
30. Lau J, Ioannidis JP, Terrin N, Schmid CH, Olkin I. The case of the misleading funnel plot. BMJ. 2006; 333 (7568): 597-600.
31. Ladabaum U, Chopra CL, Huang G, Scheiman JM, Chernew ME, Fendrick AM. Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer: a cost-effectiveness analysis. Ann Intern Med. 2001; 135 (9): 769-781.
32. Deeks JJ. Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ. 2001; 323(7305): 157-162.
33. Altman DG. Systematic reviews of evaluations of prognostic variables. BMJ. 2001; 323(7306): 224-228.
34. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet. 2001; 29(3): 306-309.
35. Lavis J, Davies H, Oxman A, Denis J, Golden-Biddle K, Ferlie E. Towards systematic reviews that inform health care management and policy-making. J Health Serv Res Policy. 2005; 10(Suppl 1): 35-48.
36. Stewart LA, Clarke MJ. Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group. Stat Med. 1995; 14(19): 2057-2079.
37. Moja LP, Telaro E, D'Amico R, Moschetti I, Coe L, Liberati A. Assessment of methodological quality of primary studies by systematic reviews : Results of the meta quality cross sectional study. BMJ. 2005; 330(7499): 1053.
38. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ; GRADE Working Group. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336(7650): 924-926.
39. Schunemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A, Fahy BF, Gould MK, Horan KL, Krishnan JA, Manthous CA, Maurer JR, McNicholas WT, Oxman AD, Rubenfeld G, Turino GM, Guyatt G; ATS Documents Development and Implementation Committee. An official ATS statement: Grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med. 2006; 174(5): 605-614.
40. Chan AW, Hrobjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles. JAMA. 2004; 291(20): 2457-2465.
41. Chan AW, Krleza-Jeric K, Schmid I, Altman DG. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ. 2004; 171(7): 735-740.
42. Silagy CA, Middleton P, Hopewell S. Publishing protocols of systematic reviews : Comparing what was done to what was planned. JAMA. 2002; 287(151): 2831-2834.